18F-Choline PET/CT Imaging for Intracranial Hemangiopericytoma RecurrenceJehanno, Nina, MD*; Cassou-Mounat, Thibaut, MD*; Mammar, Hamid, MD†; Luporsi, Marie, MD*; Huchet, Virginie, MD*Clinical Nuclear Medicine: April 2019 - Volume 44 - Issue 4 - p e305–e307 doi: 10.1097/RLU.0000000000002498 Interesting Images Buy SDC Abstract Author InformationAuthors Article MetricsMetrics We report the case of a 50-year-old man, with previous history of grade 3 intracranial hemangiopericytoma with initial complete surgical resection, addressed for local recurrence. Surgical revision performed 18 months after initial surgery allowed only partial resection, leaving residual disease along the optic nerve. Complementary radiotherapy with proton was decided. 18F-FDG PET/CT and 18F-choline PET/CT were both performed for treatment planning. 18F-FDG PET showed no uptake of the residual tumor, whereas 18F-choline depicted highly metabolic residual disease uptake with excellent delineation of local recurrence. 18F-choline PET/CT appears as a useful PET tracer for hemagiopericytoma imaging. From the Departments of *Nuclear Medicine and †Radiation Therapy and Proton Therapy, Institut Curie, PSL Research University, Paris, France. Received for publication October 24, 2018; revision accepted January 2, 2019. Conflicts of interest and sources of funding: none declared. Correspondence to: Nina Jehanno, MD, Institut Curie, 26 Rue d'Ulm, 75005 Paris, France. E-mail: email@example.com. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.